Latest Video
World Vaccine Congress Europe 2022: meet our partners!
World Vaccine Congress Europe 2022: Chats with Chaudhrey
World Vaccine Congress Europe 2022: meet our exhibitors!
World Vaccine Congress Europe 2022: meet our sponsors!
World Vaccine Congress Europe 2022 trailer!
World Vaccine Congress 2022 Washington reel!
World Vaccine Congress 2020 invitation!
World Vaccine Congress Washington 2019 trailer!
No post found
MOST POPULAR THIS MONTH
Valneva reports positive persistence data for CHIKV vaccine
Just a month after the FDA approval of its chikungunya vaccine for use in adults at risk of chikungunya virus exposure, Valneva has reported positive antibody persistence data 24 months after vaccination with IXCHIQ. These data are expected to complement the approval...
“Efficiency equals speed” for hVIVO’s Dr Andrew Catchpole
Up next in our exclusive series of Congress Conversations from the Barcelona event we are delighted to share an interview with Dr Andrew Catchpole, hVIVO. He joined us at the Congress for a presentation and a panel, sharing his insights on human challenge models. We...
Zika virus protection patch shows promise in recent study
News shared by the University of Queensland (UQ) in December 2023 explains how a paper in Molecular Therapy Nucleic Acids presents positive results from a study investigating the stability, efficacy, and immunogenicity of a DNA vaccine delivered to the skin through...
“Let communities lead!” UNAIDS report, World AIDS Day 2023
In 1988 the first World AIDS Day was launched under the theme “A world united against AIDS”; in 2023 the global health community continues to observe it, calling “let communities lead” in the UNAIDS Report 2023. WHO describes World AIDS Day as an opportunity to...
ADDomer vaccine platform has disease-fighting potential
In research shared by the University of Bristol in November 2023, a team demonstrates the validity of nature-inspired nanoparticle-based reagents using an approach that combined “synthetic, computational, and structural methods” with “in vitro antibdody selection and...
Immunotherapy innovation: myNEO Therapeutics’ Cedric Bogaert
During the Congress in Barcelona last month we were delighted to speak to so many of our fantastic speakers and exhibitors as part of our Congress Conversations series. One of these speakers was myNEO Therapeutics' Cedric Bogaert, who joined us for the cancer keynote...
Merck (MSD) shares STRIDE-3 pneumococcal vaccine insights
In November 2023 Merck, which is known as MSD outside the US and Canada, announced results from a Phase III trial evaluating the company’s investigational 21-valent pneumococcal conjugate vaccine for protection of adults. The release was followed up by details shared...
CEPI, IVI and Gambia’s MRC launch Preparedness Programme
In November 2023 CEPI, IVI, and Gambia’s Medical Research Council Unit The Gambia (MRCG) announced the launch of the Research Preparedness Programme West Africa (RPPWA). IVI will co-lead the RPPWA as “Technical Coordinating Partner”. It will support a “consortium of...
